Skip to main content

Biological Diversity by Design

Seres Therapeutics has built a proprietary discovery and design platform that enables us to understand the dysbiosis associated with specific diseases.


Product Pipeline

We are developing a novel class of biological drugs designed to treat disease by restoring the function of a dysbiotic microbiome.


Clinical Trials

We have multiple active clinical studies to evaluate our microbiome therapy clinical candidates.


Back to top